Primary care practitioners were less likely than urologists to report often or always discussing PSA testing with Black patients (19 [61.3%] vs 28 [87.5%], respectively) and patients with a family history of prostate cancer (14 [45.2%] vs 29 [90.6%]). Here, KLK3 is linked to prostate cancer.